© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Too many HIV advocates and leaders died of COVID-19, but the pandemic notwithstanding, 2020 took several AIDS icons.
COVID-19, HIV vaccines, cure news and long-acting injectables stood out among the top HIV treatment stories of the year.
A subject that didn’t even have a name this time last year came to dominate the top HIV news stories of 2020.
Read the digital edition!
Timothy Ray Brown was the first man to be cured of HIV. Following his death, he received an outpouring of appreciation on social media.
The first person cured of HIV is now in home hospice care, after a recurrence of leukemia, with his loving partner at his side.
Researchers project the Brazilian man could become the first person deemed cured of HIV without a bone marrow transplant.
Researchers studied 16 people with HIV who had received a stem cell transplant for blood cancer.
London man, who was treated for lymphoma with a stem cell transplant using HIV-resistant stem cells, is “almost certainly” cured of HIV.
A rundown of POZ’s reporting on the 2020 Conference on Retroviruses and Opportunistic Infections
The man was treated for lymphoma with a stem cell transplant using immune cells that had an uncommon, naturally occurring resistance to HIV.
“I want to be an ambassador of hope,” Adam Castillejo, 40, who grew up in Venezuela, tells The New York Times.
Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.
A second man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.
Perhaps amfAR sums it up best: “We’re certainly hopeful.”
Timothy Brown may have company after a man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.